AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24788114
Drug: Child Development
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child Development Accounts (CDAs) offered to treatment participants, based on the Oklahoma 529 College Savings Plan
Trial: 23158465
Drug: Chiropractic manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chiropractic manual therapy (individualized treatment of the spine)
Trial: 9747065
Drug: 30-mg transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-mg transdermal nicotine patch
Trial: 23403597
Drug: Dance intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dance intervention (dance classes twice weekly for 8 months, 75 minutes each class)
Trial: 12972528
Drug: Combined-modality treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined-modality treatment (CMT)
Trial: 3455945
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene kit with conventional toothbrush and self-teaching manual
Trial: 25478585
Drug: Intra-articular corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular corticosteroid injection
Trial: 16140428
Drug: L-arginine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (10 g daily for 4 weeks)
Trial: 11947910
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg once daily for 8 weeks
Trial: 2138493
Drug: Tetracycline (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline (500 mg b.d.)
Trial: 2138493
Drug: Minocycline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline (50 mg b.d.)
Trial: 27397
Drug: 0.1% dimetindene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% dimetindene maleate gel
Trial: 27397
Drug: 1% d‐chlorpheniramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% d‐chlorpheniramine maleate cream
Trial: 27718765
Drug: Vaginal ALA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal ALA 400 mg daily for 30 days
Trial: 20833455
Drug: Integrated pharmacology
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated pharmacology and medicines management curriculum
Trial: 16886113
Drug: Systemic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic chemotherapy (5‐fluorouracil, pirarubicin, mitomycin) for two courses
Trial: 16886113
Drug: Arterial infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Arterial infusion chemotherapy (5‐fluorouracil, pirarubicin, mitomycin) for four courses
Trial: 15800329
Drug: Temozolomide (TMZ)
RxNorm normalized name: Temozolomide
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Temozolomide (TMZ) 75 mg/m²/d orally concomitantly with RT (60 Gy in 30 fractions) followed by six cycles of TMZ (150 mg/m² on days 1-5 and 15-19 every 28 days)
Trial: 20084326
Drug: Oral nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nifedipine (20 mg)
Trial: 3720176
Drug: Healthy control
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy control subjects (not specified dosage)
Trial: 28631582
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) 500 mg/d for 8 weeks
Trial: 24669014
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF)
Trial: 21740089
Drug: Infrared-LED (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infrared-LED (850 nm) plus treadmill training (45 minutes twice a week for 3 months at 85%-90% HR(max), 39 mW/cm(2), fluence of 106 J/cm(2))
Trial: 19908337
Drug: Fructose-sorbitol (F-S)
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fructose-sorbitol (F-S) ingestion (25 g fructose/5 g sorbitol)
Trial: 19908337
Drug: Glucose ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose ingestion (50 g glucose)
Trial: 15160331
Drug: Standard-dose adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose adjuvant chemotherapy
Trial: 10978398
Drug: Dialysis dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysis dose (Kt/V) in conventional group
Trial: 10978398
Drug: Dialysis dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysis dose (Kt/V) in experimental group
Trial: 10978398
Drug: Erythropoietin doses
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin doses in conventional group
Trial: 9565733
Drug: Augmenting agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmenting agent with SSRI antidepressant
Trial: 9565733
Drug: SSRI antidepressant
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSRI antidepressant
Trial: 31483910
Drug: Resveratrol treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resveratrol treatment (800 mg/d for 40 days)
Trial: 26290682
Drug: Ezetimibe/Simvastatin 10/20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe/Simvastatin 10/20 mg
Trial: 16967147
Drug: Acetyl-salicylic acid
RxNorm normalized name: acetyl salicylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-salicylic acid (aspirin)
Trial: 2075082
Drug: Cefuroxime 1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 1,500 mg plus metronidazole 500 mg (3 doses)
Trial: 6163343
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of RIA and enzyme studies
Trial: 29469046
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) with AMO therapy
Trial: 25132283
Drug: Conventional restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional restorative treatment with amalgam (CRT)
Trial: 22642688
Drug: Human-voiced agent
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human-voiced agent with human-like gestures, facial expression, eye gaze, and body movement
Trial: 20124127
Drug: Intracoronary eptifibatide
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary eptifibatide administration
Trial: 16343039
Drug: Fenofibrate monotherapy
RxNorm normalized name: Fenofibrate
DrugBank: Fenofibrate (DB01039)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fenofibrate monotherapy
Trial: 11998963
Drug: Transdermal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal therapy (17beta‐estradiol 0.05 mg/d + norethisterone acetate 0.25 mg/d)
Trial: 9637637
Drug: Fentanyl-controlled ventilation
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl-controlled ventilation group (200 microg fentanyl: two doses of 50 microg and one dose of 100 microg, spaced 6 min)
Trial: 2678520
Drug: Triampur (TP)
RxNorm normalized name: OTX-TP
DrugBank: Travoprost (DB00287)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Triampur (TP) - doubled doses
Trial: 811075
Drug: Carbamazepine in
RxNorm normalized name: carbamazepine Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine in combination with phenobarbital and diphenylhydantoin
Trial: 31160244
Drug: Internet-delivered Cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered Cognitive Behaviour Therapy (iCBT) for Fear of Birth
Trial: 25919978
Drug: Pain interference
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pain interference during treatment in COMBINE
Trial: 25919978
Drug: Pain interference
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pain interference following treatment in COMBINE
Trial: 25919978
Drug: Pain interference
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pain interference following treatment in COMBINE (after controlling for other factors)
Trial: 3544622
Drug: Metoprolol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (200 mg/day)
Trial: 10825304
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no beta-blockers)
Trial: 16424650
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ferrous iron supplement (as fumarate)
Trial: 16424650
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg ferrous iron supplement (as fumarate)
Trial: 7664435
Drug: d-sotalol 200
RxNorm normalized name: sotalol hydrochloride 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-sotalol 200 mg BID
Trial: 7664435
Drug: d-sotalol 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-sotalol 50 mg BID
Trial: 7664435
Drug: d-sotalol 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-sotalol 100 mg BID
Trial: 31142156
Drug: Acupuncture (weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture (weekly for 3 months)
Trial: 31142156
Drug: Phytoestrogens (soy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytoestrogens (soy isoflavones 75 mg/2/d for 3 months)
Trial: 29390421
Drug: Celecoxib-based chemotherapy
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Celecoxib-based chemotherapy
Trial: 24911964
Drug: 7 mg
RxNorm normalized name: pectin 7 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 mg lycopene daily for 2 months
Trial: 20347837
Drug: 12 weekly
RxNorm normalized name: elagolix
DrugBank: Elagolix (DB11979)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12 weekly classes of yoga
Trial: 16477954
Drug: Morphine (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (intravenous injections of 0.1 mg/kg)
Trial: 16477954
Drug: Placebo (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intravenous injections of 0.9% NaCl)
Trial: 10500826
Drug: High anthracycline
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High anthracycline dose intensity (H/A)
Trial: 10500826
Drug: Low anthracycline
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low anthracycline dose intensity (L/A)
Trial: 2403448
Drug: Tamoxifen 40
RxNorm normalized name: tamoxifen 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 40 mg by mouth four times a day
Trial: 23570538
Drug: Inpatient hybrid
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient hybrid closed-loop therapy (HCLC)
Trial: 23570538
Drug: Outpatient sensor‐augmented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient sensor‐augmented pump (SAP) therapy
Trial: 9232210
Drug: AMPT (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMPT (1 g p.o. T.I.D.)
Trial: 29468069
Drug: Broad-spectrum antibiotics
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broad-spectrum antibiotics
Trial: 30621711
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline treatment in blank and model groups
Trial: 27193737
Drug: Supportive expressive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive expressive group therapy (SET)
Trial: 22682024
Drug: Interceptor long-lasting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interceptor long-lasting insecticidal nets (200 mg/m² alpha-cypermethrin)
Trial: 17698804
Drug: High-dose sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose sequential chemotherapy with PBSC support (two cycles of cyclophosphamide and paclitaxel followed by three cycles of HD carboplatin and paclitaxel with PBSC support, HD melphalan added to the final cycle)
Trial: 17698804
Drug: Standard combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard combination chemotherapy
Trial: 17698804
Drug: High-dose sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose sequential chemotherapy with PBSC support
Trial: 26580093
Drug: Investigational vaccine
RxNorm normalized name: INVESTIGATIONAL VACCINES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Investigational vaccine (Shan5™)
Trial: 23549123
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml ropivacaine 7.5 mg/ml
Trial: 23549123
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml 0.9% saline
Trial: 17570651
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg three times a day with low-calorie diet
Trial: 26050853
Drug: Tualang honey
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tualang honey + antibiotic
Trial: 2203467
Drug: Antibiotic only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic only
Trial: 21209031
Drug: Antiandrogenic oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiandrogenic oral contraceptive
Trial: 10500311
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (20 mg IV bolus followed by 60 mg infusion over 1 hour)
Trial: 10500311
Drug: Single bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single bolus (80 mg)
Trial: 10500311
Drug: Split bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split bolus (2 x 40 mg at 30-minute intervals)
Trial: 1785240
Drug: Aminophylline (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (3 mg.kg‐1)
Trial: 19150139
Drug: Codeine/acetaminophen (C/A)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine/acetaminophen (C/A)
Trial: 14569512
Drug: Clinical response
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical response evaluation after 2 cycles of chemotherapy
Trial: 10533734
Drug: Intrasphincteric injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrasphincteric injection of botulinum toxin A (20 U injected into each of the four quadrants in the lower esophageal sphincter)
Trial: 30012909
Drug: Double-level Retrolaminar
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-level Retrolaminar Paravertebral Block (RLB) with 15 ml ropivacaine (0.5%) for each lamina of T2 and T4 vertebrae
Trial: 633779
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g cephradine with 40 mg furosemide t.i.d. peroral
Trial: 633779
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g cephalothin
Trial: 20804454
Drug: naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen 500 mg twice daily (n = 59)
Trial: 16419643
Drug: 185 mg
RxNorm normalized name: amdinocillin 185 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 185 mg GCE once a day
Trial: 12640589
Drug: Quetiapine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine at a mean dose of 24.9 mg/d
Trial: 22450386
Drug: hT(2)W‐3D‐FLAIR obtained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hT(2)W‐3D‐FLAIR obtained 10 min, 3.5 hours, and 4 hours after GBCM administration in Group A
Trial: 22450386
Drug: hT(2)W‐3D‐FLAIR obtained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hT(2)W‐3D‐FLAIR obtained before and 10 min, 4 hours, and 4.5 hours after GBCM administration in Group B
Trial: 18797646
Drug: Brief intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief intervention and contact (BIC) plus treatment as usual
Trial: 11262469
Drug: Intravenously administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenously administered iron sucrose plus recombinant human erythropoietin
Trial: 9525542
Drug: Warfarin anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin anticoagulation
Trial: 3443154
Drug: Fenoterol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol 1.25 mg
Trial: 7125306
Drug: Fenoterol 2.5
RxNorm normalized name: fenoterol 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol 2.5 mg
Trial: 31261570
Drug: YIC therapeutic
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: YIC therapeutic vaccine
Trial: 23602291
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose IV omega-3 polyunsaturated fatty acids (PUFAs)
Trial: 19008718
Drug: Telmisartan 80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 80 mg for 3 months
Trial: 19008718
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg for 3 months
Trial: 11081989
Drug: Pycnogenol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pycnogenol (100 mg 2-3 times/day for 2 months)
Trial: 9322471
Drug: Epidural bolus
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural bolus of clonidine 150 micrograms plus morphine 2 mg
Trial: 9322471
Drug: Epidural patient-controlled
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural patient-controlled analgesia (PCEA) with bupivacaine 0.25% and sufentanil 2 micrograms/mL
Trial: 30209353
Drug: Curcumin +
RxNorm normalized name: Nature's Truth Turmeric Curcumin + Ginger Gummies (Peach)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin + Fish Oil (1.2 g)
Trial: 30209353
Drug: Fish Oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish Oil (1.2 g)
Trial: 24373369
Drug: Mud-bath therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mud-bath therapy
Trial: 25122648
Drug: 1.3 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.3 g/d of EPA+DHA from fish oil (FO)
Trial: 25122648
Drug: 0.9 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 g/d of EPA+DHA from fish oil (FO)
Trial: 21531577
Drug: Subcutaneous treprostinil
RxNorm normalized name: Treprostinil
DrugBank: Treprostinil (DB00374)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Subcutaneous treprostinil treatment
Trial: 12062463
Drug: Minimal methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal methadone treatment with daily INH DOPT (n=35)
Trial: 12062463
Drug: Routine care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine care referral to TB clinic for monthly INH supplies without DOPT and without methadone treatment (n=39)
Trial: 9058223
Drug: Mivacurium chloride
RxNorm normalized name: Mivacurium Chloride
DrugBank: Mivacurium (DB01226)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mivacurium chloride 0.15 mg/kg
Trial: 8533541
Drug: Mivacurium chloride
RxNorm normalized name: Mivacurium Chloride
DrugBank: Mivacurium (DB01226)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mivacurium chloride 0.19 mg/kg
Trial: 8533541
Drug: Mivacurium chloride
RxNorm normalized name: Mivacurium Chloride
DrugBank: Mivacurium (DB01226)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mivacurium chloride (all doses)
Trial: 2170852
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg BC-PS
Trial: 2170852
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg BC-PS
Trial: 27192505
Drug: Paper patch
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper patch technique
Trial: 1099449
Drug: Oral delta‐9‐tetrahydrocannabinol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral delta‐9‐tetrahydrocannabinol
Trial: 30311701
Drug: Elbasvir 50
RxNorm normalized name: elbasvir 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elbasvir 50 mg/grazoprevir 100 mg once daily for 12 weeks
Trial: 11826641
Drug: 1% sodium
RxNorm normalized name: Dextrose 5% and 0.11% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% sodium hyaluronate (HA) 6 mg, injected in the upper compartments of the involved TMJs, three to four injections as one course.
Trial: 11826641
Drug: Prednisolone (PS)
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone (PS) 12.5 mg, injected once a week, three to four injections as one course.
Trial: 10599905
Drug: Systemic doxycycline
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic doxycycline at a dosage of 100 mg/day for 14 days